The perioperative nutritional status is a potential prognostic factor in gastric cancer patients. This study assessed the optimal cut-off value of the prognostic nutritional index (PNI) for predicting the survival of patients with early stage gastric cancer and evaluated its power for predicting the survival after gastric cancer surgery. Materials and Methods: This study reviewed the data of 8,014 patients with stage T1N0~1M0 and T2~3N0M0 gastric cancer who underwent a curative gastrectomy without adjuvant chemotherapy between January 2006 and December 2015. The log-rank test on SAS was conducted to determine the preoperative PNI cut-off value that indicated the most significant difference in survival, and the clinical features and oncological outcomes were analyzed according to the cut-off value of the preoperative PNI. Results: The preoperative PNI cut-off value that indicated the most significant difference in survival was 43.7. Using this cut-off value, patients were classified into high PNI and low PNI groups. The five-year overall survival rate was 96.9% and 81.5% for the high and low PNI group, respectively (P<0.001). Considering each stage (Ia, Ib, and IIa), the overall survival rates were significantly higher for the high PNI group than the low PNI group. Multivariable analysis revealed the cut-off value of the preoperative PNI to be among the independent risk factors for survival. Conclusions: The cut-off value of the preoperative PNI that could be used to determine the significant differences in the survival of patients with early stage gastric cancer was identified and proven to have a significant impact on predicting survival. (Surg Metab Nutr 2019;10:59-65)
INTRODUCTION
Although the incidence of gastric cancer has decreased in most parts of the world, it is still the 5th most common malignancy and the 2nd most common cause of cancer death worldwide. [1] However, owing to the development of screening programs, the diagnosis of early gastric cancer has increased and the survival outcomes are excellent, [2, 3] indicating that adequate postoperative care as well as the choice of the surgical procedure are becoming increasingly important in the field of gastric cancer treatment.
The nutritional status of patients has received much attention as a potential prognostic factor in cancer treatment including gastric cancer. [4, 5] Even though the prognostic impact of the nutritional status in patients with gastric cancer was not considered to be as important as the pathological tumor stage, we previously showed that various nutritional parameters were associated with the survival of patients with gastric cancer. [5] Unlike tumor stage, as the nutritional status of patients can be im- The significance of the prognostic nutritional index (PNI) has been widely reported and confirmed in many types of cancers. For example, in gastric cancer, a lower PNI was associated with a more aggressive tumor, higher recurrence, poor overall survival, and higher risk of postoperative complications. [6] [7] [8] Moreover, some authors have suggested the optimal cut-off value of the PNI for predicting the survival of patients with gastric cancer. [7] However, the PNI values are not widely used in clinical practice for gastric cancer because the aggressive nature of the tumor and the need for adjuvant chemotherapy followed by surgery were important factors that resulted in better survival and the association between nutritional status and tumor aggressiveness is not clear. Therefore, in this study, we enrolled patients with early stage gastric cancer, that is stage Ia (T1N0M0), Ib (T2N0M0, T1N1M0), and only T3N0M0 out of stage IIawho are free from the effects of the aggressive nature of the tumor and the need for adjuvant chemotherapy-to evaluate the prognostic impact of the nutritional status.
MATERIALS AND METHODS

Patients
Between January 2006 and December 2015, the data of 8,014 patients with stage Ia (T1N0M0), Ib (T2N0M0, T1N1M0), and only T3N0M0 out of stage IIa gastric cancer who underwent curative gastrectomy without adjuvant chemotherapy were retrospectively collected and reviewed. Tumors were staged according to the 7th American Joint Committee on Cancer Staging System. [9] Patients with a previous history of other malignancy, gastric surgery, neoadjuvant chemotherapy, or radiotherapy were excluded. 
Data collection
Statistical analysis
To calculate the preoperative PNI value that indicated the most significant difference in survival, we used the log-rank test of SAS. As P-values are close to zero, we used the formula "-log10 (P-value)" to obtain a negative value for ease of interpretation. When the value of the "-log10 (P-value)" is the highest, i.e., when the P-value is the smallest, the preoperative PNI at that point is considered to be the cut-off value. On the basis of the results of this analysis, the point with the smallest P-value was selected as the optimal value of the preoperative PNI.
Then, patients were divided into two groups according to the cut-off value of the PNI. Several clinicopathological characteristics and long-term outcome of the two groups were compared by using the SPSS statistical software, version 24 (Chicago, IL, USA). The continuous variables between the groups were compared using the independent t-test, and the categorical data were analyzed by using the chi-squared test. The overall survival rate was estimated using Kaplan-Meier survival curves. The association between potential risk factors and outcomes and the independent effects on overall survival rate were evaluated by using Cox proportional-hazards regression analysis. The differences with P-values ＜0.05 were considered statistically significant. the high PNI group and 81.5% for the low PNI group ( Fig.   2A , P＜0.001). In addition, the overall survival rates were significantly higher in the high PNI group than in the low PNI group considering stage Ia (Fig. 2B, 97 .6% vs. 82.4%), stage Ib (Fig. 2C, 95 .0% vs. 77.8%) and stage IIa (Fig. 2D,   85 .2% vs. 81.0%). A significant association was identified between the preoperative PNI and overall survival rate.
RESULTS
Baseline clinicopathological characteristics and cut-off value of the PNI
Long-term outcomes
Role of the cut-off value of the preoperative PNI as a prognostic marker
On univariable analysis, old age, male sex, low preoperative PNI, low BMI, total gastrectomy, high ASA score, advanced stage, differentiated histology, low PNI at 3, 6, and 12 months postoperatively were significantly associated with worse prognosis, as shown in Table 3 . On multivariable analysis using a Cox regression model, the low preoperative PNI (＜43.7) was among the independent risk factors predicting poor survival.
DISCUSSION
The perioperative nutritional status is associated with In the current study, we focused on the long-term survival of patients with early stage gastric cancer considering the nutritional status. In advanced gastric cancer, the tumor stage is the strongest predictive factor for tumor recurrence and survival, and advanced cancer is associated with gastrointestinal symptoms, weight loss, and cachexia. Moreover, adjuvant chemotherapy can also affect the nutritional status of patients with symptoms of anorexia, vomiting, abdominal pain, and diarrhea.
Therefore, we included patients with early tumor stage, that is stage Ia (T1N0M0), Ib (T2N0M0, T1N1M0), and only T3N0M0 out of stage IIa, thereby omitting the effects of tumor stage and chemotherapy on the nutritional status and survival of patients.
The cut-off values of the PNI for postoperative survival of patients with gastric cancer have been calculated in previous studies by using the criteria of low 10 percentile, mean value, or multiple logistic regression analysis. Using the PNI value is a very easy method to determine the nutritional status as well as predict patient survival and postoperative complications. Because the preoperative nutritional status can be improved via oral or parenteral supplementation, surgeons can reduce the risk of developing postoperative complications and improve the short-term and long-term outcomes of patients. Even though other factors such as age, sex, tumor stage, and histology were significant for predicting overall survival on multivariable analysis, the only modifiable factor before surgery is the nutritional status. Therefore, although the postoperative PNI values were not significant prognostic factors in our study, we should evaluate the association between the postoperative PNI and survival of patients with advanced gastric cancer who receive adjuvant chemotherapy after surgery.
In conclusion, the preoperative PNI was an independent prognostic factor in patients with stage I and IIa (only T3N0M0 out of stage IIa) gastric cancer who underwent curative gastrectomy without adjuvant chemotherapy. Surgeons should pay attention to the nutritional status of patients with gastric cancer before surgery and make an effort to improve it, especially in patients with a low PNI value (＜43.7).
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